10 Stocks Ray Dalio and Insiders Are Piling Into

In this article, we discuss 10 stocks Ray Dalio and insiders are piling into. If you want to see more stocks in this selection, check out 5 Stocks Ray Dalio and Insiders Are Piling Into

Amid a volatile stock market environment, investors are turning towards insiders, billionaires, and famous money managers, in order to replicate their trades or get an idea about the near-term outlook based on their market moves. With Q3 earnings season coming to a close and several mega-cap stocks down meaningfully year-to-date, there is a chance for insiders to extend a vote of confidence by buying up their own company shares.

Investors giving up on stocks because of recession fears amid an uncertain market backdrop may want to reconsider their actions, as insiders at prominent companies like The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG) are going on buying sprees. It is also a good idea to observe billionaire money managers like Ray Dalio, the founder of Bridgewater Associates, which controls a $20 billion stock portfolio as of the end of the third quarter of 2022. In an interview with Barron’s on November 11, Dalio explained his outlook on the economy in the following words: 

“When the next big downturn occurs, and the economic pain is greater than the inflation pain, you will see the Fed and other central banks continue money-printing to monetize debt. Then, real rates will go down again, money will become cheaper and more plentiful, and inflation-hedge assets and new innovation/technology-company equities will be most attractive.”

Our Methodology 

We used Ray Dalio’s hedge fund Q3 2022 portfolio for this analysis, selecting his largest stock positions which have also had an insider purchase in the last 6 months. We have arranged the list according to the number of hedge fund holders in each firm, tracked by Insider Monkey as of the second quarter of 2022.

10 Stocks Ray Dalio and Insiders Are Piling Into

Stocks Ray Dalio and Insiders Are Piling Into

10. Sysco Corporation (NYSE:SYY)

Number of Hedge Fund Holders: 32

Sysco Corporation (NYSE:SYY) is an American multinational corporation engaged in distributing food products, kitchen equipment, and tabletop items to restaurants, healthcare and educational facilities, and hospitality businesses. In Q3 2022, Ray Dalio boosted his Sysco Corporation (NYSE:SYY) stake by 1%, holding 1.68 million shares worth about $119 million. On June 21, 2022, an insider also purchased 1,000 units of Sysco Corporation (NYSE:SYY)’s common stock. 

On November 1, Sysco Corporation (NYSE:SYY) reported its financial results for the quarter ending September 2022. The company posted a non-GAAP EPS of $0.97, falling short of market estimates by $0.02. The revenue of $19.13 billion climbed 15.9% on a year-over-year basis, beating Wall Street consensus by $430 million. 

Argus analyst John Staszak on November 2 raised the price target on Sysco Corporation (NYSE:SYY) to $96 from $92 and kept a Buy rating on the shares. Despite the FQ1 earnings miss, the analyst is optimistic about Sysco Corporation (NYSE:SYY)’s efforts to offset weak food sales to restaurants and hotels by controlling costs and focusing on sales to grocery stores. 

According to Insider Monkey’s data, 32 hedge funds were bullish on Sysco Corporation (NYSE:SYY) at the end of Q2 2022, compared to 31 funds in the prior quarter. Nelson Peltz’s Trian Partners held the biggest stake in the company, comprising 8.8 million shares worth about $745 million. 

Like The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG), Sysco Corporation (NYSE:SYY) is one of the stocks that insiders are piling into. 

9. Starbucks Corporation (NASDAQ:SBUX)

Number of Hedge Fund Holders: 55

Ray Dalio’s Bridgewater Associates owns nearly 3 million shares of Starbucks Corporation (NASDAQ:SBUX) as of the third quarter of 2022, worth $252.5 million and representing 1.27% of the total 13F securities. On September 15, two directors at the coffee giant purchased a total of 64,750 common shares priced at about $92.5 each. In Q3 2022, Starbucks Corporation (NASDAQ:SBUX) reported that comparable store sales increased 7% globally – gaining 11% in the United States and double digits internationally, excluding China. 

On November 4, Evercore ISI analyst David Palmer raised the price target on Starbucks Corporation (NASDAQ:SBUX) to $97 from $95 and maintained an Outperform rating on the shares, telling investors that he is “less worried” about FY23 sales and earnings following the company’s Q3 report. He lifted his FY23 EPS estimate to $3.39 from $3.25, which now reflects U.S. same-store sales growth of 8.5%, up from 7.5%.

According to Insider Monkey’s data, 55 hedge funds were long Starbucks Corporation (NASDAQ:SBUX) at the end of Q2 2022, compared to 58 funds in the prior quarter. D E Shaw held a prominent stake in the company, comprising 2.68 million shares worth $204.7 million. 

Here is what Polen Global Growth has to say about Starbucks Corporation (NASDAQ:SBUX) in its Q2 2022 investor letter:

“Starbucks, which garners a lower weighting in the Portfolio, had slightly better than average three-month performance. Same Store sales were up double-digits in the U.S. and International exChina, with solid revenue growth across those regions. The company is experiencing cost pressures from wages and input costs though, and China same-store sales were down 23% due to zero-COVID policy restrictions and lockdowns.”

8. CME Group Inc. (NASDAQ:CME)

Number of Hedge Fund Holders: 56

CME Group Inc. (NASDAQ:CME) is an Illinois-based company that operates a financial derivatives exchange for the trading of asset classes such as agricultural products, currencies, energy, interest rates, metals, stock indexes, and cryptocurrencies futures. Ray Dalio owns 318,263 shares of CME Group Inc. (NASDAQ:CME) as of Q3 2022, worth $56.3 million and representing 0.28% of his total 13F portfolio. On November 4, CME Group Inc. (NASDAQ:CME)’s director also purchased close to 49,000 shares priced at $170 per unit. 

On November 10, CME Group Inc. (NASDAQ:CME) declared a $1.00 per share quarterly dividend, in line with previous. The dividend is distributable on December 28, to shareholders of the company as of December 9. CME Group Inc. (NASDAQ:CME)’s dividend yield on November 14 came in at 2.27%. 

Deutsche Bank analyst Brian Bedell on October 27 raised the price target on CME Group Inc. (NASDAQ:CME) to $202 from $200 and kept a Buy rating on the shares following the “good” Q3 results.

According to Insider Monkey’s data, 56 hedge funds were bullish on CME Group Inc. (NASDAQ:CME) at the end of June 2022, compared to 58 funds in the prior quarter. GuardCap Asset Management held the leading position in the company, comprising 4.2 million shares worth approximately $859 million. 

Here is what Baron Durable Advantage Fund has to say about CME Group Inc. (NASDAQ:CME) in its Q1 2022 investor letter:

“CME Group, Inc. (NASDAQ:CME) operates the world’s largest and most diversified derivatives marketplace. Shares rose 4.6%, contributing to results as elevated market volatility and rising interest rates led to higher trading activity on CME’s exchanges. Average daily trading volume increased 19% year-over-year with notable strength in Interest Rates and Equities products. We continue to own the stock due to CME’s strong competitive moats, underpinned by its product breadth and liquidity depth, as well as its sustainable growth characteristics driven by the secular shift from uncleared over-the-counter trading to exchange-traded futures while also benefiting from the rising rate environment.”

7. The Coca-Cola Company (NYSE:KO)

Number of Hedge Fund Holders: 60

Securities filings for the third quarter of 2022 reveal that Ray Dalio’s Bridgewater Associates owns 11.4 million shares of The Coca-Cola Company (NYSE:KO), worth $642.3 million and representing 3.25% of the total portfolio. On October 28, a director at The Coca-Cola Company (NYSE:KO) also purchased 33,200 shares priced at $60.18 each. 

The Coca-Cola Company (NYSE:KO) posted market-beating Q3 results and global unit case volume grew 4%. For the full-year 2022, the company expects to deliver organic revenue growth of 14% to 15%. On October 20, The Coca-Cola Company (NYSE:KO) declared a quarterly dividend of $0.44 per share, in line with previous. The dividend is payable on December 15, to shareholders of record on December 1. 

On October 26, UBS analyst Peter Grom raised the price target on The Coca-Cola Company (NYSE:KO) to $68 from $63 and kept a Buy rating on the shares. The company’s Q3 earnings beat was “impressive” as its organic growth largely offset currency headwinds, the analyst told investors in a research note. 

According to Insider Monkey’s Q2 data, 60 hedge funds were bullish on The Coca-Cola Company (NYSE:KO), compared to 64 funds in the prior quarter. Warren Buffett’s Berkshire Hathaway held the largest stake in the company, consisting of 400 million shares worth over $25 billion. 

Here is what Aristotle Capital specifically said about The Coca-Cola Company (NYSE:KO) in its Q2 2022 investor letter:

“The Coca-Cola Company (NYSE:KO), the global beverage business, was a leading contributor for the period. Coca-Cola continues to benefit from the re-franchising of its bottling operations and realignment of incentives, catalysts we previously identified. These initiatives are demonstrating their strength in an inflationary and supply-chain-challenged environment. Additionally, the company has focused on evolving its customer engagement practices by leveraging digital and social media for targeted campaigns, such as the design and launch of Coke Byte in the metaverse. Lastly, Coca-Cola has furthered its transformation into a total beverage company, as it debuted its new Jack Daniel’s Tennessee Whiskey and Coca-Cola ready-to-drink premixed cocktail. Although uncertainties surrounding cost pressures, lockdowns and geopolitical conflicts remain, we believe Coca-Cola is uniquely positioned to successfully continue its transition toward a total beverage business.”

6. HCA Healthcare, Inc. (NYSE:HCA)

Number of Hedge Fund Holders: 63

HCA Healthcare, Inc. (NYSE:HCA) provides healthcare services in the United States. The company operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, emergency services, and outpatient services. Ray Dalio’s Bridgewater Associates owns 372,040 shares of HCA Healthcare, Inc. (NYSE:HCA) worth $68.3 million as of Q3 2022. Patricia Elcan, a large shareholder of HCA Healthcare, Inc. (NYSE:HCA), purchased 325 shares of the company priced at $198.66 each on July 25. 

On October 21, HCA Healthcare, Inc. (NYSE:HCA) declared a $0.56 per share quarterly dividend, in line with previous. The dividend is payable on December 28, to shareholders of the company as of December 14. 

Citi analyst Jason Cassorla on October 26 raised the price target on HCA Healthcare, Inc. (NYSE:HCA) to $251 from $240 and kept a Buy rating on the shares following the Q3 results.

According to Insider Monkey’s Q2 data, 63 hedge funds were long HCA Healthcare, Inc. (NYSE:HCA), compared to 62 funds in the prior quarter. Harris Associates is the largest stakeholder of the company, with 7.75 million shares worth $1.30 billion. 

In addition to The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG), HCA Healthcare, Inc. (NYSE:HCA) is backed by elite hedge funds and insiders alike. 

Here is what Diamond Hill Capital Management specifically said about HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2022 investor letter:

“HCA Healthcare, Inc. (NYSE:HCA) is a best-in-class operator of acute care hospitals and other health care facilities, including outpatient surgery centers. It has a strong market presence in highly attractive geographies with growing populations and low unemployment, such as Texas and Florida, which leads to a favorable payor mix. We are further attracted to its strong management team that has a stellar track record of deploying capital, and the founding family continues to own almost a quarter of the business. We initiated a position after HCA reported Q1 earnings — it reduced full year guidance due to increased labor costs and lower-than-expected acuity among COVID admissions, dampening near-term investor sentiment.”

Click to continue reading and see 5 Stocks Ray Dalio and Insiders Are Piling Into

Suggested articles:

Disclosure: None. 10 Stocks Ray Dalio and Insiders Are Piling Into is originally published on Insider Monkey.